Rigel Pharma surged 50.1% due to strong revenue drivers, strategic partnerships, and undervaluation, justifying a Strong Buy ...

No matter what happens, investing in companies that will get through bear markets and perform well over the long run is ...

Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...

Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...

India's pharmaceutical and meditech exports continue to grow despite global economic slowdown, with robust double-digit ...

Releaf® Announces Partnership with SOMAÍ Pharmaceuticals to Bring Innovative Cannabis Solutions to UK Patients ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Astrazeneca plc is adding a preclinical-stage candidate to its cardiovascular pipeline via a potentially $2 billion licensing agreement with CSPC Pharmaceutical Group Ltd., which includes a $100 ...

Jonathan Chang, an analyst from Leerink Partners, maintained the Buy rating on Vincerx Pharma Inc (VINC – Research Report). The ...

AstraZeneca, a United Kingdom-based biopharmaceutical giant, will add 10 to 15 new projects to the company's research and ...

For an exclusive license to the preclinical Lp(a) disruptor, AstraZeneca is paying CSPC Pharmaceutical Group $100 million ...